BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12619164)

  • 1. t(10;16)(q22;p13) and MORF-CREBBP fusion is a recurrent event in acute myeloid leukemia.
    Vizmanos JL; Larráyoz MJ; Lahortiga I; Floristán F; Alvarez C; Odero MD; Novo FJ; Calasanz MJ
    Genes Chromosomes Cancer; 2003 Apr; 36(4):402-5. PubMed ID: 12619164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusion of the MORF and CBP genes in acute myeloid leukemia with the t(10;16)(q22;p13).
    Panagopoulos I; Fioretos T; Isaksson M; Samuelsson U; Billström R; Strömbeck B; Mitelman F; Johansson B
    Hum Mol Genet; 2001 Feb; 10(4):395-404. PubMed ID: 11157802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYST3/CREBBP (MOZ/CBP) and CREBBP/MYST3 (CBP/MOZ) transcripts in AML with t(8;16)(p11;p13).
    Schmidt HH
    Genes Chromosomes Cancer; 2005 Feb; 42(2):207-8; author reply 209. PubMed ID: 15540217
    [No Abstract]   [Full Text] [Related]  

  • 4. Genomic characterization of MOZ/CBP and CBP/MOZ chimeras in acute myeloid leukemia suggests the involvement of a damage-repair mechanism in the origin of the t(8;16)(p11;p13).
    Panagopoulos I; Isaksson M; Lindvall C; Hagemeijer A; Mitelman F; Johansson B
    Genes Chromosomes Cancer; 2003 Jan; 36(1):90-8. PubMed ID: 12461753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RT-PCR analysis of acute myeloid leukemia with t(8;16)(p11;p13): identification of a novel MOZ/CBP transcript and absence of CBP/MOZ expression.
    Panagopoulos I; Fioretos T; Isaksson M; Mitelman F; Johansson B; Theorin N; Juliusson G
    Genes Chromosomes Cancer; 2002 Dec; 35(4):372-4. PubMed ID: 12378533
    [No Abstract]   [Full Text] [Related]  

  • 6. RT-PCR analysis of the MOZ-CBP and CBP-MOZ chimeric transcripts in acute myeloid leukemias with t(8;16)(p11;p13).
    Panagopoulos I; Isaksson M; Lindvall C; Björkholm M; Ahlgren T; Fioretos T; Heim S; Mitelman F; Johansson B
    Genes Chromosomes Cancer; 2000 Aug; 28(4):415-24. PubMed ID: 10862050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling of acute myeloid leukemia with translocation t(8;16)(p11;p13) and MYST3-CREBBP rearrangement reveals a distinctive signature with a specific pattern of HOX gene expression.
    Camós M; Esteve J; Jares P; Colomer D; Rozman M; Villamor N; Costa D; Carrió A; Nomdedéu J; Montserrat E; Campo E
    Cancer Res; 2006 Jul; 66(14):6947-54. PubMed ID: 16849538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein.
    Borrow J; Stanton VP; Andresen JM; Becher R; Behm FG; Chaganti RS; Civin CI; Disteche C; Dubé I; Frischauf AM; Horsman D; Mitelman F; Volinia S; Watmore AE; Housman DE
    Nat Genet; 1996 Sep; 14(1):33-41. PubMed ID: 8782817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of inv(8)(p11q24) associated with acute myeloid leukemia involves the MOZ and CBP genes in a masked t(8;16).
    Chaffanet M; Mozziconacci MJ; Fernandez F; Sainty D; Lafage-Pochitaloff M; Birnbaum D; Pébusque MJ
    Genes Chromosomes Cancer; 1999 Oct; 26(2):161-5. PubMed ID: 10469454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NCOA3, a new fusion partner for MOZ/MYST3 in M5 acute myeloid leukemia.
    Esteyries S; Perot C; Adelaide J; Imbert M; Lagarde A; Pautas C; Olschwang S; Birnbaum D; Chaffanet M; Mozziconacci MJ
    Leukemia; 2008 Mar; 22(3):663-5. PubMed ID: 17805331
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute myeloid leukemia with t(8;16)(p11.2;p13.3)/KAT6A-CREBBP in adults.
    Xie W; Hu S; Xu J; Chen Z; Medeiros LJ; Tang G
    Ann Hematol; 2019 May; 98(5):1149-1157. PubMed ID: 30759270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RT-PCR and FISH analysis of acute myeloid leukemia with t(8;16)(p11;p13) and chimeric MOZ and CBP transcripts: breakpoint cluster region and clinical implications.
    Schmidt HH; Strehl S; Thaler D; Strunk D; Sill H; Linkesch W; Jäger U; Sperr W; Greinix HT; König M; Emberger W; Haas OA
    Leukemia; 2004 Jun; 18(6):1115-21. PubMed ID: 15085163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel fusion variant of the MORF and CBP genes detected in therapy-related myelodysplastic syndrome with t(10;16)(q22;p13).
    Kojima K; Kaneda K; Yoshida C; Dansako H; Fujii N; Yano T; Shinagawa K; Yasukawa M; Fujita S; Tanimoto M
    Br J Haematol; 2003 Jan; 120(2):271-3. PubMed ID: 12542485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute myeloid leukemia with translocation (8;16)(p11;p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene.
    Díaz-Beyá M; Navarro A; Ferrer G; Díaz T; Gel B; Camós M; Pratcorona M; Torrebadell M; Rozman M; Colomer D; Monzo M; Esteve J
    Leukemia; 2013 Mar; 27(3):595-603. PubMed ID: 23022987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FISH identifies a KAT6A/CREBBP fusion caused by a cryptic insertional t(8;16) in a case of spontaneously remitting congenital acute myeloid leukemia with a normal karyotype.
    Barrett R; Morash B; Roback D; Pambrun C; Marfleet L; Ketterling RP; Harrison K; Berman JN
    Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28097792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission of acute monocytic leukemia, secondary to treatment with epipodophyllotoxins, in a patient with t(8;16)(p11;p13) and MYST3-CREBBP fusion.
    Vizmanos JL; Larráyoz MJ; Vázquez I; Odero MD; Hernández R; Lahortiga I; Novo FJ; Ardanaz MT; Calasanz MJ
    Cancer Genet Cytogenet; 2004 Jul; 152(2):177-8. PubMed ID: 15262444
    [No Abstract]   [Full Text] [Related]  

  • 17. Abnormalities of chromosome band 8p11 in leukemia: two clinical syndromes can be distinguished on the basis of MOZ involvement.
    Aguiar RC; Chase A; Coulthard S; Macdonald DH; Carapeti M; Reiter A; Sohal J; Lennard A; Goldman JM; Cross NC
    Blood; 1997 Oct; 90(8):3130-5. PubMed ID: 9376594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. t(8;16)(p11;p13) predisposes to a transient but potentially recurring neonatal leukemia.
    Wong KF; Yuen HL; Siu LL; Pang A; Kwong YL
    Hum Pathol; 2008 Nov; 39(11):1702-7. PubMed ID: 18657848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. t(11;16)(q23;p13)/KMT2A-CREBBP in hematologic malignancies: presumptive evidence of myelodysplasia or therapy-related neoplasm?
    Xie W; Tang G; Wang E; Kim Y; Cloe A; Shen Q; Zhou Y; Garcia-Manero G; Loghavi S; Hu AY; Wang S; Bueso-Ramos CE; Kantarjian HM; Medeiros LJ; Hu S
    Ann Hematol; 2020 Mar; 99(3):487-500. PubMed ID: 32006151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary acute monocytic leukemia with a translocation t(8;22)(p11;q13).
    Tasaka T; Nagai M; Matsuhashi Y; Uehara E; Tamura T; Ishida T; Kakazu N; Abe T
    Haematologica; 2002 May; 87(5):ECR19. PubMed ID: 12010682
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.